Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human Trial.
Front Immunol
; 12: 694759, 2021.
Article
in En
| MEDLINE
| ID: mdl-34335606
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Plasmodium falciparum
/
Vaccines, Synthetic
/
Malaria, Falciparum
/
Malaria Vaccines
/
Immunogenicity, Vaccine
Type of study:
Clinical_trials
Limits:
Humans
Country/Region as subject:
Europa
Language:
En
Journal:
Front Immunol
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: